enVVeno cites Journal of Vascular Surgery study showing venous valve therapy saves more than $32,000 per patient over five years

• enVVeno Medical highlighted a peer-reviewed health economic analysis published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders.
• Results were already presented via publication, positioning venous valve replacement as both clinically beneficial and lower cost than conservative care.
• The study projected more than USD 32,000 in per-patient healthcare savings over five years, supporting a reimbursement case for enVVeno’s enVVe system.
• Management plans to apply forthcoming clinical data from the TAVVE pivotal trial to the published model to support coverage decisions.
• The analysis estimated USD 5.9 billion in annual healthcare savings with broader adoption, underscoring a large commercial opportunity.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enVVeno Medical Corp. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608040846ACCESSWRNAPR_____1201042) on August 04, 2026, and is solely responsible for the information contained therein.